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LETTERS TO THE EDITOR 
Regarding "Comparison of  endovascular nd 
conventional vascular prostheses in an experimental 
infection model" 
To the Editors: 
With great interest we read the article by Parsons et al. 
(J Vase Surg 1996;24:920-6), which suggested that endo- 
vascular prostheses have a higher rate of infection than 
vascular prostheses implanted in conventional surgery in an 
experimental model. Our clinical and experimental studies 
do not confirm completely their conclusion. 1,2 Therefore, 
we would like to add our experience with endoluminal 
repair of infrarenal aortic aneurysms. 
Since September 1994 we have performed endolumi- 
hal repair for exclusion ofinfrarenal aneurysm with use of a 
polyester textile-covered nitinol stent) ,2 In a series of 83 
patients treated endoluminally, no graft infection oc- 
curred. The mean follow-up period is 18 months, ranging 
from 8 days to 32 months. Our follow-up protocol in- 
cludes clinical examination, intraarterial ngiography, and 
spiral computed tomography. 
However, there is an inflammatory esponse in all pa- 
tients after endoluminal stent graft implantation. With a 
delay of 6 hours after aortic endografting, elevation of 
C-reactive protein (range, 8.4 to 24.8 mg/dl) and leuko- 
cytosis (range, 8.4 to 27.8 x 103/ram 3) developed in all 
patients. Elevated body temperature (range, 38.0 ° to 
39.8 ° C) developed in half of the patients. There was no 
evidence of bacteremia. 2 
Our experimental nd immunologic studies howed a 
significant and uniform elevation ofinterleukin 6, which is 
suspected to be responsible for proinflammatory reaction. 
The graft material acts most likely as a foreign body. This 
reaction is self-limiting, with laboratory findings becoming 
normal within 8 days. 
According to these clinical and experimental data, our 
current policy includes the following regimen for endolu- 
minal repair ofinfrarenal aneurysms: (1) administration of
a single dose of broad-spectrum antibiotics (cephalospo- 
tin) periprocedurally; and (2) only symptomatic antiin- 
flammatory treatment. 
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Reply 
To the Editors: 
We read with interest he letter by Schlensak, Blum, 
Spillner, and Beyersdorf, which refers to their experience 
excluding infrarenal aneurysms 'with the use of a polyester 
textile-covered nitinol stent. In their series of 83 patients, 
they have noted a significant inflammatory response with 
the endoluminal graft implantation but have noted no 
significant infection. We congratulate them for their good 
results in this group of patients. We have noted similar 
findings in our 62 patients who have undergone endolumi- 
nal repair of aortoiliac aneurysms. This inflammatory re- 
sponse has also been noted in our series of 55 patients who 
have undergone placement of an endoluminal graft for 
aortoiliac occlusive disease. We have not observed any 
significant graft infection in any of these patients, either. 
However, these observations are irrelevant to our arti- 
cle. The article in question documents that if an experi- 
mental endovascular p osthesis gets infected, the infection 
is more virulent than after a standard repair. This article 
does not attempt to discuss the incidence of infection after 
endovascular g afting. The world's experience with endo- 
vascular grafts is in its infancy, and the rate of infection is 
still not clear. Our paper merely suggests that if an infec- 
tion develops in an endoluminal graft, the infection is likely 
to be more virulent han that encountered after placement 
of a standard prosthetic arterial graft. 
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Regarding "Stent deformation and intimal 
hyperplasia complicating treatment of  a post-carotid 
endarterectomy intimal flap with a Palmaz stent" 
To the Editors: 
In the article by recently published by Johnson, Fuji- 
tani, Leyendecker, and Joseph (J Vase Surg 1997;25:764- 
8), several questions arise in the endovascular management 
of this particular patient. 
The choice of a JJIS 294 stent in a cervical segment, 
common carotid lesion may not have been the most logical 
choice. In the IDE-sponsored registry for carotid occlusive 
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